© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cefathiamidine stands out as a first-generation cephalosporin antibiotic, designed to target a broad range of Gram-positive bacteria. Its primary applications include the treatment of respiratory infections, skin and soft tissue infections, and urinary tract infections. The compound is recognized in both clinical and veterinary settings for its reliable performance and safety track record. Unlike some newer antibiotics, it offers effective action without widespread resistance, an important factor considering the growing global concern about antimicrobial resistance. Pharmacologically, this cephalosporin inhibits cell wall synthesis by binding to specific penicillin-binding proteins in bacteria, leading to cell lysis and death. Clinicians often rely on cefathiamidine because of its relatively low toxicity, favorable pharmacokinetics, and established effectiveness.
Cefathiamidine appears as a white to off-white crystalline powder, known for its high level of purity in pharmaceutical-grade stocks. Its precise melting point ranges from 154°C to 163°C, which helps labs identify the compound and ensures stability during formulation. Although primarily available in powder form, cefathiamidine sometimes takes shape as irregular flakes or minute crystals. Storage in cool, dry conditions under sealed containers prevents degradation and keeps its potency intact. Its density falls close to 1.7 g/cm³ at room temperature, and the compound demonstrates modest solubility in water, usually requiring gentle shaking or mild sonication to achieve a uniform solution. The material can easily convert to a sterile, injectable solution for clinical use after reconstitution, which is essential in hospital settings.
The molecular formula for cefathiamidine is C16H17N7O4S2, supporting a molecular weight of about 451.48 g/mol. Structurally, the compound contains a beta-lactam ring fused with a dihydrothiazine ring, which forms the core of the cephalosporin scaffold. Thiazole and amidine groups extend from this core, providing the unique activity profile that distinguishes cefathiamidine from other cephalosporins. Chemists often discuss the precise orientation of substituents, because these influence how the antibiotic interacts with target bacterial enzymes. Its three-dimensional arrangement has been studied in depth, as even minor changes to the side chains can alter both safety and effectiveness.
Pharmacists, researchers, and suppliers receive cefathiamidine in tightly sealed vials, ampoules, or foil packets. Purity levels often exceed 98%. Pharmaceutical quality control labs regularly screen for moisture levels below 1%, as excess water can degrade potency. Production batches carry clear lot numbers and expiry dates to support traceability and safety across supply chains. The compound arrives as a free-flowing powder, with occasional lot variations showing it as pearl-like granules or irregular flakes—an expected outcome of the crystallization process. Rare liquid forms reach end users only as part of ready-to-use injectable solutions. Packaging often references weight per liter, with typical densities supporting clear labeling.
Cefathiamidine’s global trade operates under the Harmonized System (HS) Code 2941.90, covering antibiotics prepared for retail sale. This classification streamlines customs clearance for manufacturers and distributors, so that hospitals and pharmacies worldwide receive consistent, high-quality product. Regulatory compliance stands as a baseline requirement, and each shipment usually provides detailed documentation of manufacturing and quality assurance practices. Pharmacopoeias in several countries include official monographs on cefathiamidine, which keep product standards high and ensure that medicine cabinets stock safe, verified material.
Though cefathiamidine scores highly on safety when administered as directed, manufacturing workers and laboratory users must heed strict handling guidelines. Direct skin or eye contact with the raw powder can cause minor irritation for sensitive individuals. Inhalation of fine particles, though uncommon, remains a concern in bulk pharmaceutical operations. Proper protective gear—masks, gloves, and goggles—limits risk during weighing, mixing, or solution preparation. Emergency procedures outline immediate washing of affected skin or mucous membranes. Guidelines from OSHA and similar agencies often cover the safe storage and disposal of raw materials and expired product, keeping environmental and workplace risks low. Once inside the human body, cefathiamidine shows low toxicity except for rare allergic responses typical of all beta-lactams.
Molecularly, cefathiamidine arranges itself as a compact, rigid structure, consistent with other cephalosporins. The molecule’s tightly packed beta-lactam core provides strength and specific reactivity. Its measured density remains consistent across batches, which simplifies the formulation process. Pharmacists and industrial chemists rely on this predictability for large-scale weighing and mixing. Suppliers can reliably distribute cefathiamidine as a fine, snow-white powder, although alternate forms like pearls or crystalline flakes occasionally appear in different process streams. Once dissolved in water, cefathiamidine forms a clear or slightly opalescent solution, ready for final dilution or direct injection, as required by clinical guidelines.
Sourcing cefathiamidine raw material draws on lessons learned in wider pharmaceutical manufacturing. Laboratory analysts test incoming lots for both purity and stability, so unanticipated degradation products remain rare. Transportation in temperature-controlled vehicles keeps the compound pure from factory to hospital. The solid nature of the product simplifies inventory storage, limits accidental spills, and extends shelf life—qualities essential for any essential medicine included on medical formularies. Sufficient documentation allows instant checks for batch history, supporting trust among users and regulators even in emergency scenarios.
